Amy H. Seung, PharmD, BCOP, CHCP, FHOPA is the Vice President of Oncology Pharmacy Strategy for MJH Life Sciences, the parent company of Pharmacy Times and PTCE (Pharmacy Times Continuing Education). In her role, she drives innovation and growth by aligning pharmacists' needs to enhance patient care with strategic partnerships and new business opportunities. Previously she was the Senior Director of Clinical Development at AssistRx, where she led clinical strategy for a medication management platform. Dr. Seung initially practiced at Johns Hopkins Hospital in the roles of Oncology Clinical Decision Support and Hematologic Malignancies Pharmacy Clinical Specialists, and also served as Director of the PGY2 Oncology Pharmacy Residency Program.

Dr. Seung received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill and completed her Pharmacy Practice and Oncology Specialty Residencies at the University of Washington Medical Center and Seattle Cancer Care Alliance in Seattle, WA.

Dr. Seung has been supporting HOPA for many years in a variety of leadership and member roles within committees and task forces. She has authored multiple oncology articles and oncology pharmacotherapy book chapters, and spoken nationally on leukemias, oncology medication, specialty pharmacy, and digital technology topics.